abstract |
Provided are a urea compound represented by the general formula (I), a pharmaceutically acceptable salt thereof, a method for preparing the same, and particularly the use thereof as an FLT3 tyrosine protein kinase inhibitor in the prevention and/or treatment of cancer. |